pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,690 catalysts · 5,347 phase readout · 2,315 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 20 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: phase readout×type: filing×clear all
type
  • phase readout5,347
  • 8k filing2,315
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07612865: People's Hospital of Xinjiang Uygur Autonomous Region

Sponsor: People's Hospital of Xinjiang Uygur Autonomous Region. Phase: NA. Conditions: Cervical Cancer, Venous Thromboembolism, Lymphedema

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07381465: Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus

Sponsor: Chinese SLE Treatment And Research Group. Phase: PHASE4. Conditions: Lupus Erythematosus, Systemic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07431411: Reproductive Health Education, Birth Control and Sexual Quality of Life in Ectopic Pregnancy

Sponsor: Buket Kömürcü. Phase: NA. Conditions: Ectopic Pregnancy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07396311: Fractional Exhaled Nitric Oxide and Exacerbations of COPD

Sponsor: Chang Gung Memorial Hospital. Phase: . Conditions: Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07436611: Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

Sponsor: AFT Pharmaceuticals, Ltd.. Phase: PHASE2. Conditions: Port Wine Stains

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06704971: Assessing Cognitive Decline at Home

Sponsor: Stanford University. Phase: . Conditions: Mild Cognitive Impairment, Mild Dementia, Dementia Alzheimers, Dementia, Memory Impairment, NPS

full page →ctgov ↗
›COMPLETEDphase readoutNCT05765344: Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Hepatic Impairment, Healthy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07637734: Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

Sponsor: Verrica Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts

full page →ctgov ↗
›RECRUITINGphase readoutNCT05858034: Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: HIV, Aging

full page →ctgov ↗
›RECRUITINGphase readoutNCT05959434: Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD

Sponsor: Texas A&M University. Phase: PHASE2. Conditions: Posttraumatic Stress Disorder, Alcohol Use Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06626334: Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma

Sponsor: Rebecca E Kotcher, MD. Phase: NA. Conditions: Rib Fractures, Pain, Acute

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04994132: A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Metastatic Embryonal Rhabdomyosarcoma, Metastatic Rhabdomyosarcoma, Solid Alveolar Rhabdomyosarcoma, Spindle Cell Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06827132: Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer

Sponsor: AstraZeneca. Phase: . Conditions: Lung Cancer, Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06786832: Characterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care

Sponsor: Karolinska Institutet. Phase: NA. Conditions: Fatigue, Fatigue Post Viral, Exhaustion Disorder, Fatigue Symptom, Fatigue Related to Cancer Treatment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07374198: Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression

Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Depression, Anxiety, S-ketamine, Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07505563: MiniFlo for Advanced Dupuytren's Disease

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona. Phase: NA. Conditions: Dupuytren's Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07256093: The Effectiveness of Acceptance and Commitment Therapy (ACT) on Dysfunctional Attitudes and Difficulties in Emotion Regulation Among University Students in Malaysia

Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Anxiety, Depression, Stress

full page →ctgov ↗
›COMPLETEDphase readoutNCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07700121: PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: EARLY_PHASE1. Conditions: Unresectable or Metastatic Melanoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06327321: Vitiligo Treatment by Targeting TYK2 Mediated Responses

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE2. Conditions: Vitiligo, Generalized

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07415616: Cold vs Warm Enteral Feeding and Gastric Emptying in Adult ICU Patients

Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital. Phase: NA. Conditions: Gastric Emptying, Enteral Nutrition (Food for Special Medical Purposes)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07579416: Bruxism, Anxiety, and Periodontal Status Among Dental Students

Sponsor: Al-Hawash Private University. Phase: . Conditions: Bruxism, Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477704: A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Hypercholesterolemia

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07382804: Mobile Behavioral Activation Program With Wearable Sensors and Secure Activity Verification

Sponsor: Truway Health, Inc.. Phase: NA. Conditions: Health Behavior, Behavioral Activation, Sedentary Behavior

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07680504: A Pilot Superiority Study Comparing the Efficacy of a Combination of a Glenohumeral Intra-articular Injection With a Suprascapular Nerve Block Versus a Glenohumeral Intra-articular Corticosteroid Injection in Retractile Capsulitis

Sponsor: Nantes University Hospital. Phase: PHASE2. Conditions: Retractile Capsulitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05139004: 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07383584: The Impact of Extending Sleep Before Joint-replacement Surgery on Post-surgical Pain

Sponsor: Defense and Veterans Center for Integrative Pain Management. Phase: NA. Conditions: Joint (Knee or Hip Replacement)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07698184: The Condition of the Temporomandibular Joint in Hemiplegia

Sponsor: Ayşe Ukbe Baykut. Phase: . Conditions: Hemiplegia, Temporomandibular Disorder (TMD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT00009633: Follow-up Visit of High Risk Infants

Sponsor: NICHD Neonatal Research Network. Phase: . Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07664033: AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients: A Pilot Study

Sponsor: IRCCS Eugenio Medea. Phase: NA. Conditions: Neuromotor Impairments

full page →ctgov ↗
›COMPLETEDphase readoutNCT03489733: Prevention of Allergic Diseases in Infants

Sponsor: HiPP GmbH & Co. Vertrieb KG. Phase: NA. Conditions: Atopic Diseases

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05967533: The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

Sponsor: University of California, Davis. Phase: PHASE1. Conditions: Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Melanoma, Advanced Renal Cell Carcinoma, Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer (AJCC) v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT06508333: Efficacy and Safety of Vitamin D Supplementation Combined With Alarm Therapy in Treating Nocturnal Enuresis

Sponsor: Xing Liu. Phase: NA. Conditions: Enuresis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05863052: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Sponsor: University of Oklahoma. Phase: . Conditions: Immune Checkpoint Inhibitors, Metastatic Solid Tumor, Nonsmall Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Gastrointestinal Cancer, Squamous Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04529252: Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

Sponsor: Mayo Clinic. Phase: . Conditions: Spinocerebellar Ataxias, Cerebellar Ataxia, Nucleotide Repeat Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT04544852: Uncovering and Overcoming the Barriers of Colorectal Cancer Screening Amongst Spouses of Patients With Colorectal Cancer

Sponsor: National University Health System, Singapore. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT03997552: NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration

Sponsor: Universidad de Murcia. Phase: NA. Conditions: Periodontitis, Periodontal Diseases, Periodontal Pocket

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07689188: Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

Sponsor: Harrison Dermatology. Phase: PHASE2. Conditions: Hidradenitis Suppurativa (HS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06408103: Efficacy of a Multicomponent Intervention on Cognitive Function for the Caregiver-patient Dyad

Sponsor: Universidad de Santander. Phase: NA. Conditions: Mild Cognitive Impairment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07524803: Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)

Sponsor: Latin American Consortium for the Lung Cancer Research. Phase: . Conditions: Lung Cancer Screening

full page →ctgov ↗
›RECRUITINGphase readoutNCT06280703: A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Healthy, Type 1 Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07352527: New Clinical Decision Support Score Based on Steroid Hormone Profiling in the Diagnosis of MACS

Sponsor: University Hospital, Bordeaux. Phase: . Conditions: Endocrine Disease

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05870527: Pupillary Dilation During Post-Auricular Vagal Nerve Stimulation

Sponsor: NYU Langone Health. Phase: NA. Conditions: Hearing Loss

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06491927: Long Term Follow-up for RGX-202

Sponsor: REGENXBIO Inc.. Phase: . Conditions: Duchenne Muscular Dystrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07336017: Impact on Postpartum Anal Incontinence of an Educational Program for Delivery Room Staff

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Anal Incontinence

full page →ctgov ↗
›RECRUITINGphase readoutNCT05883540: Lysergic Acid Diethylamide (LSD) in Palliative Care

Sponsor: University Hospital, Basel, Switzerland. Phase: PHASE2. Conditions: Palliative Care, Pain, Anxiety, Depression, Demoralization, Psychological Distress, Quality of Life, Caregiver Burden, Fear of Death, Existential Distress

full page →ctgov ↗
›COMPLETEDphase readoutNCT05265689: Study to Improve Adolescent Bicycling Safety

Sponsor: Cara J. Hamann. Phase: NA. Conditions: Bicycling, Knowledge, Adolescent, Self Efficacy, Education, Attitudes, Practice, Safety, Behavior

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07499089: Together-Breast Cancer Support Platform

Sponsor: Cedars-Sinai Medical Center. Phase: . Conditions: Breast Cancer, Breast Cancer Survivors

full page →ctgov ↗
›COMPLETEDphase readoutNCT07396350: IMMEDIATE IMPLANT With Different Types of Membrane

Sponsor: Mansoura University. Phase: NA. Conditions: Tooth Extraction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07416591: Role of Saline Infusion Sonohysterography in Detection of Pelvic Adhesions in Infertile Women

Sponsor: Sohag University. Phase: NA. Conditions: Infertile Women With Pelvic Adhesions

full page →ctgov ↗
← prev
page 93 of 114
next →